Session Information
2010 Clinical Endocrinology Update
Click here to go to the previous page
Panel Q&A
Track
:
Saturday October 2, 2010
Program Code:
530
Date:
Saturday, October 2, 2010
Time:
12:20 PM to 12:50 PM
EST
Location:
Los Angeles Room
SPEAKER
(S):
R. Michael Tuttle, MD, Mem Sloan Kettering Cancer
Disclosure:R. Michael Tuttle, MD, has received consultant fees from Abbott, Genzyme, Lilly and Novo Nordisk.
Disclosure:R. Michael Tuttle, MD, has received consultant fees from Abbott, Genzyme, Lilly and Novo Nordisk.
Robert F. Gagel, MD, U of TX MD Anderson Cancer CtrDisclosure:Robert F. Gagel, MD, has served as consultant for AstraZeneca, Eisai Pharmaceuticals, Amgen and Exelixis; received research grant support from AstraZeneca; served as a speaker for Exelixis.
Description
Panel Q&A
Audio Synchronized to PowerPoint
(Code: 530)
This session is a part of: